Catalyst Wire Dossier Catalyst Wire Dossier

Desvenlafaxine hydrochloride (sustained-release formulation)

Desvenlafaxine hydrochloride · Jiangsu Hansoh Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Desvenlafaxine hydrochloride (sustained-release formulation), covering 2013-11-06 to 2013-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder [Phase 2, Phase 3]

See pricing